Jasbir Sra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jasbir Sra has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
David Krum
Electrophysiology Laboratories of Aurora Sinai/Aurora St. Luke’s Medical Center University of Wisconsin School of Medicine and Public Health-Milwaukee Clinical Campus
17 shared publicationsMasood Akhtar
Electrophysiology Laboratories of Aurora St. Luke's and Aurora Sinai Medical Centers, University of Wisconsin School of Medicine and Public Health‐Milwaukee Clinical Campus, Milwaukee, Wisconsin, USA
13 shared publicationsAnwer Dhala
Electrophysiology Laboratories of Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health‐Milwaukee Clinical Campus, Milwaukee, Wisconsin, USA
6 shared publicationsAtul Bhatia
Electrophysiology Laboratories of Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health‐Milwaukee Clinical Campus, Milwaukee, Wisconsin, USA
6 shared publicationsAngela Malloy
Electrophysiology Laboratories of Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health‐Milwaukee Clinical Campus, Milwaukee, Wisconsin, USA
5 shared publicationsRyan Cooley
Electrophysiology Laboratories of Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health‐Milwaukee Clinical Campus, Milwaukee, Wisconsin, USA
5 shared publications
Latest Publications
- 1 November 2009
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 20 (11) , 1279-1283
Incessant Interfascicular Reentrant Ventricular Tachycardia as a Result of Catheter Ablation of the Right Bundle Branch: Case Report and Review of the Literature
- 1 November 2009
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 20 (11) , 1279-1283
Incessant Interfascicular Reentrant Ventricular Tachycardia as a Result of Catheter Ablation of the Right Bundle Branch: Case Report and Review of the Literature
- 6 October 2009
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 20 (10) , 1170-1172
A Case of Flecainide‐Induced Hyponatremia
We present a case of flecainide‐induced hyponatremia in a 67‐year‐old woman who was treated for paroxysmal atrial tachycardia. She developed dizziness after starting flecainide and was found to be hyponatremic with a sodium level of 122 mmol/L (decreased from 136 mmol/L). Work‐up failed to reveal other causes of hyponatremia. She was not on diuretics, laxatives, or herbal medications. After discontinuation of flecainide, her symptoms and sodium levels improved. Hyponatremia is a previously unrecognized entity as an adverse effect of flecainide. We will discuss the clinical presentation, lab findings, and a possible explanation for this patient's unusual reaction to flecainide.
- 6 October 2009
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 20 (10) , 1170-1172
A Case of Flecainide‐Induced Hyponatremia
We present a case of flecainide‐induced hyponatremia in a 67‐year‐old woman who was treated for paroxysmal atrial tachycardia. She developed dizziness after starting flecainide and was found to be hyponatremic with a sodium level of 122 mmol/L (decreased from 136 mmol/L). Work‐up failed to reveal other causes of hyponatremia. She was not on diuretics, laxatives, or herbal medications. After discontinuation of flecainide, her symptoms and sodium levels improved. Hyponatremia is a previously unrecognized entity as an adverse effect of flecainide. We will discuss the clinical presentation, lab findings, and a possible explanation for this patient's unusual reaction to flecainide.
- 1 April 2008
- Published by Elsevier in Heart Rhythm
- Vol. 5 (4) , 609-617
Cardiac image registration of the left atrium and pulmonary veins
- 1 April 2008
- Published by Elsevier in Heart Rhythm
- Vol. 5 (4) , 609-617
Cardiac image registration of the left atrium and pulmonary veins
- 27 March 2008
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 22 (2) , 167-172
Atrial fibrillation ablation complications
Atrial fibrillation (AF) is a common arrhythmia. Although significant work still needs to be done, recent advances in understanding the mechanisms of AF have led to the development of elegant catheter mapping techniques for ablation of AF, complemented by the evolution of various imaging and navigational technologies. Due to the complexity of the arrhythmia, and the significant length of time needed to successfully ablate in the left atrium, it is imperative that an acceptable risk–benefit profile be defined. Various complications, some of them serious, have been reported in the last several years. This review addresses the potential risks of AF ablation and how to avoid some of these complications.
- 27 March 2008
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 22 (2) , 167-172
Atrial fibrillation ablation complications
Atrial fibrillation (AF) is a common arrhythmia. Although significant work still needs to be done, recent advances in understanding the mechanisms of AF have led to the development of elegant catheter mapping techniques for ablation of AF, complemented by the evolution of various imaging and navigational technologies. Due to the complexity of the arrhythmia, and the significant length of time needed to successfully ablate in the left atrium, it is imperative that an acceptable risk–benefit profile be defined. Various complications, some of them serious, have been reported in the last several years. This review addresses the potential risks of AF ablation and how to avoid some of these complications.
- 25 March 2008
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 22 (2) , 145-154
Cardiac image integration implications for atrial fibrillation ablation
Cardiac image registration using computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and fluoroscopy is currently being investigated and clinically used for atrial fibrillation (AF) ablation. Cardiac image registration, in the context of left atrium, is intermodal, with the acquired image and the real-time reference image residing in different image spaces, and involves optimization, where one image space is transformed into the other. Geometry-based methods, which include using fiducial points and/or surface-based techniques, are usually used for cardiac image registration. During fiducial point registration, fiducial points are either external skin markers or manually determined by marking anatomical landmarks, using mapping catheters. Usually, a minimum of three non collinear points are needed for optimal registration. Recently, a catheter placed inside the coronary sinus has also been used as a fiducial marker for the purpose of registration. During surface registration, the process involves characterizing surfaces in each of the images and deriving the best transformation between them. Unlike rigid body registration, such as has been extensively used in imaging the brain, cardiac image registration is unique and challenging. In addition to the errors inherent in intermodal registration, such as errors in pixel and voxel dimension and errors due to fiducial point selection, there are errors specific to cardiac image registration, i.e., errors due to cardiac motion during the cardiac cycle and due to respiration. This review addresses the basic principles of registration and the inherent registration errors as they relate to cardiac imaging and registration.
- 25 March 2008
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 22 (2) , 145-154
Cardiac image integration implications for atrial fibrillation ablation
Cardiac image registration using computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and fluoroscopy is currently being investigated and clinically used for atrial fibrillation (AF) ablation. Cardiac image registration, in the context of left atrium, is intermodal, with the acquired image and the real-time reference image residing in different image spaces, and involves optimization, where one image space is transformed into the other. Geometry-based methods, which include using fiducial points and/or surface-based techniques, are usually used for cardiac image registration. During fiducial point registration, fiducial points are either external skin markers or manually determined by marking anatomical landmarks, using mapping catheters. Usually, a minimum of three non collinear points are needed for optimal registration. Recently, a catheter placed inside the coronary sinus has also been used as a fiducial marker for the purpose of registration. During surface registration, the process involves characterizing surfaces in each of the images and deriving the best transformation between them. Unlike rigid body registration, such as has been extensively used in imaging the brain, cardiac image registration is unique and challenging. In addition to the errors inherent in intermodal registration, such as errors in pixel and voxel dimension and errors due to fiducial point selection, there are errors specific to cardiac image registration, i.e., errors due to cardiac motion during the cardiac cycle and due to respiration. This review addresses the basic principles of registration and the inherent registration errors as they relate to cardiac imaging and registration.
- 13 February 2008
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 19 (4) , 362-366
Periprocedural Anticoagulation for Atrial Fibrillation Ablation
Background: Catheter ablation for atrial fibrillation (AF) can increase risk of left atrial (LA) thrombi and stroke. Optimal periprocedural anticoagulation has not been determined. Objective: We report the role of administering warfarin and aspirin without low molecular weight heparin in patients undergoing AF ablation. Methods: A total of 207 patients underwent ablation for AF. Transesophageal echocardiography (TEE) guided transseptal puncture and ruled out clot in the LA. After first puncture, the sheath was flushed with heparin (5,000 Units/mL). After second puncture, a bolus of 80 units/kg of heparin was given, followed by an infusion to maintain activated clotting time (ACT) around 300–350 seconds. Warfarin was stopped and aspirin was started (325 mg/day) 3 days preprocedure. Warfarin was restarted on the day of the procedure. Both medications were continued for 6 weeks postablation. Warfarin was continued for 6 months in patients with prior history of persistent or recurrent AF. Thirty‐seven patients who showed smoke in the LA on TEE were given low molecular weight heparin postprocedure until international normalized ratio (INR) was therapeutic. Results: Thirty‐two patients had persistent and 175 had paroxysmal AF; 87 were cardioverted during ablation. Two patients had transient ischemic attack (TIA) on the sixth and eighth days, respectively, following ablation, with complete recovery. Both had subtherapeutic INRs. Conclusion: In patients without demonstrable clot or smoke in the LA, starting aspirin 3 days prior and warfarin immediately post‐radiofrequency ablation, without low molecular weight heparin, with meticulous anticoagulation during the procedure, appears to be a safe mode of anticoagulation.
- 13 February 2008
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 19 (4) , 362-366
Periprocedural Anticoagulation for Atrial Fibrillation Ablation
Background: Catheter ablation for atrial fibrillation (AF) can increase risk of left atrial (LA) thrombi and stroke. Optimal periprocedural anticoagulation has not been determined. Objective: We report the role of administering warfarin and aspirin without low molecular weight heparin in patients undergoing AF ablation. Methods: A total of 207 patients underwent ablation for AF. Transesophageal echocardiography (TEE) guided transseptal puncture and ruled out clot in the LA. After first puncture, the sheath was flushed with heparin (5,000 Units/mL). After second puncture, a bolus of 80 units/kg of heparin was given, followed by an infusion to maintain activated clotting time (ACT) around 300–350 seconds. Warfarin was stopped and aspirin was started (325 mg/day) 3 days preprocedure. Warfarin was restarted on the day of the procedure. Both medications were continued for 6 weeks postablation. Warfarin was continued for 6 months in patients with prior history of persistent or recurrent AF. Thirty‐seven patients who showed smoke in the LA on TEE were given low molecular weight heparin postprocedure until international normalized ratio (INR) was therapeutic. Results: Thirty‐two patients had persistent and 175 had paroxysmal AF; 87 were cardioverted during ablation. Two patients had transient ischemic attack (TIA) on the sixth and eighth days, respectively, following ablation, with complete recovery. Both had subtherapeutic INRs. Conclusion: In patients without demonstrable clot or smoke in the LA, starting aspirin 3 days prior and warfarin immediately post‐radiofrequency ablation, without low molecular weight heparin, with meticulous anticoagulation during the procedure, appears to be a safe mode of anticoagulation.
- 17 October 2007
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 20 (1) , 37-38
CT-Fluoro registration-guided ablation of the left atrium in atrial fibrillation
- 17 October 2007
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 20 (1) , 37-38
CT-Fluoro registration-guided ablation of the left atrium in atrial fibrillation
- 19 April 2007
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 18 (6) , 623-627
Biventricular Pacing and QT Interval Prolongation
The purpose of this study was to examine BiV pacing-dependent changes in QT interval and the related potential for proarrhythmia. Biventricular (BiV) pacing has emerged as a promising therapy for patients with advanced congestive heart failure (CHF) and bundle branch block (BBB). One hundred and seventy-six consecutive patients (123 men and 53 women; mean age 67 +/- 16 years) with ischemic (n = 128) or nonischemic (n = 48) cardiomyopathy in New York Heart Association Class II (8%) or III (92%) CHF (ejection fraction 24 +/- 9%) underwent atrial synchronous BiV pacing. The QRS, QT, and JT intervals were measured at 30 minutes after initiation of BiV pacing, at 24 hours, and at 1 month postimplant. QT interval was defined as the time interval between the initial deflection of the QRS complex and the point at which the T wave crossed the isoelectric line. At baseline, the average QRS duration was 178 +/- 10 ms, attributable to left BBB (n = 158) or intraventricular conduction delay (n = 18). BiV pacing resulted in a small but statistically significant reduction in QRS duration (148 +/- 9 ms during BiV pacing vs 178 +/- 10 ms at baseline [P < 0.0001]), yet the QT increased to 470 +/- 34 ms with BiV pacing versus 445 +/- 32 ms at baseline [P < 0.0001]). The JTc interval during BiV pacing was significantly shorter than during LV pacing (290 +/- 9 ms vs 320 +/- 20 ms, P < 0.0001). During a mean follow-up of 24 +/- 6 months, one patient developed recurrent torsade de pointes. That was eliminated once left ventricular pacing was discontinued. Biventricular pacing prolongs QT interval. However, the occurrence of torsade de pointes is uncommon.
- 19 April 2007
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 18 (6) , 623-627
Biventricular Pacing and QT Interval Prolongation
The purpose of this study was to examine BiV pacing-dependent changes in QT interval and the related potential for proarrhythmia. Biventricular (BiV) pacing has emerged as a promising therapy for patients with advanced congestive heart failure (CHF) and bundle branch block (BBB). One hundred and seventy-six consecutive patients (123 men and 53 women; mean age 67 +/- 16 years) with ischemic (n = 128) or nonischemic (n = 48) cardiomyopathy in New York Heart Association Class II (8%) or III (92%) CHF (ejection fraction 24 +/- 9%) underwent atrial synchronous BiV pacing. The QRS, QT, and JT intervals were measured at 30 minutes after initiation of BiV pacing, at 24 hours, and at 1 month postimplant. QT interval was defined as the time interval between the initial deflection of the QRS complex and the point at which the T wave crossed the isoelectric line. At baseline, the average QRS duration was 178 +/- 10 ms, attributable to left BBB (n = 158) or intraventricular conduction delay (n = 18). BiV pacing resulted in a small but statistically significant reduction in QRS duration (148 +/- 9 ms during BiV pacing vs 178 +/- 10 ms at baseline [P < 0.0001]), yet the QT increased to 470 +/- 34 ms with BiV pacing versus 445 +/- 32 ms at baseline [P < 0.0001]). The JTc interval during BiV pacing was significantly shorter than during LV pacing (290 +/- 9 ms vs 320 +/- 20 ms, P < 0.0001). During a mean follow-up of 24 +/- 6 months, one patient developed recurrent torsade de pointes. That was eliminated once left ventricular pacing was discontinued. Biventricular pacing prolongs QT interval. However, the occurrence of torsade de pointes is uncommon.
- 23 February 2007
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 17 (2) , 103-109
Pulmonary vein isolation and linear lesions in atrial fibrillation ablation
Various strategies have been used for atrial fibrillation (AF) ablation. It is unclear whether adding linear lesions to pulmonary vein (PV) isolation has significant advantages. We assessed the clinical benefit of adding linear lesions in patients undergoing PV isolation for AF. One hundred patients (63 male and 37 female; mean age of 59 ± 11 years) with documented paroxysmal AF were included in the study. Patients were randomized into two groups. The first group underwent PV isolation alone. The second group underwent PV isolation and had two linear lesions created; one line between the superior PVs, and a second line from the left inferior PV to the mitral valve annulus. Patients’ clinical progress after the ablation was evaluated and compared at 1, 3, and 9 months after their respective ablation procedures. The linear lesions group maintained sinus rhythm and had fewer symptoms than the lone PV isolation group (86 vs. 58%, respectively) (p < 0.05) at 1 month. At 9 months, when patients who reverted to AF underwent additional management to regain sinus rhythm (90 vs. 82%, respectively) (p = NS), there was no statistical difference between the groups regarding the use of antiarrhythmics, the need for electrical cardioversion, and subjective improvement. The addition of linear lesions to PV isolation more effectively achieved sinus rhythm initially and fewer patients required additional management to maintain their rhythm when compared to patients who underwent lone PV isolation. However, at 9 months, the overall results were similar in both groups.
- 23 February 2007
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 17 (2) , 103-109
Pulmonary vein isolation and linear lesions in atrial fibrillation ablation
Various strategies have been used for atrial fibrillation (AF) ablation. It is unclear whether adding linear lesions to pulmonary vein (PV) isolation has significant advantages. We assessed the clinical benefit of adding linear lesions in patients undergoing PV isolation for AF. One hundred patients (63 male and 37 female; mean age of 59 ± 11 years) with documented paroxysmal AF were included in the study. Patients were randomized into two groups. The first group underwent PV isolation alone. The second group underwent PV isolation and had two linear lesions created; one line between the superior PVs, and a second line from the left inferior PV to the mitral valve annulus. Patients’ clinical progress after the ablation was evaluated and compared at 1, 3, and 9 months after their respective ablation procedures. The linear lesions group maintained sinus rhythm and had fewer symptoms than the lone PV isolation group (86 vs. 58%, respectively) (p < 0.05) at 1 month. At 9 months, when patients who reverted to AF underwent additional management to regain sinus rhythm (90 vs. 82%, respectively) (p = NS), there was no statistical difference between the groups regarding the use of antiarrhythmics, the need for electrical cardioversion, and subjective improvement. The addition of linear lesions to PV isolation more effectively achieved sinus rhythm initially and fewer patients required additional management to maintain their rhythm when compared to patients who underwent lone PV isolation. However, at 9 months, the overall results were similar in both groups.
- 30 January 2007
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 18 (4) , 409-414
Computed Tomography‐Fluoroscopy Image Integration‐Guided Catheter Ablation of Atrial Fibrillation
Introduction: This study examines the feasibility of atrial fibrillation (AF) ablation using registered three‐dimensional computed tomography (CT) images of the left atrium with fluoroscopy. Methods and Results: A total of 50 consecutive patients with symptomatic AF refractory to medical therapy (32 paroxysmal, 18 persistent, age 55 ± 10 years) were randomized to undergo a catheter‐based AF ablation procedure with or without the CT‐fluoroscopy guidance system. All patients underwent preprocedural contrast‐enhanced CT imaging and segmentation of the left atrium. For the CT‐fluoroscopy group, circumferential lesions encompassing the pulmonary vein (PV) antrum and linear lesions along the roof of the left atrium between the superior PVs and the mitral isthmus were created on the CT image, which was registered with real‐time fluoroscopy. The registered images were then used to navigate the ablation catheters to the sites of planned ablation. After the ablation sites were completed, any remaining PV potentials were isolated with electrophysiological guidance. In the control patients, the same technique was performed without using the CT‐fluoro guidance system. CT scans were accurately registered to fluoroscopic images with minimal manual correction. Operators could navigate catheters on the registered images to preplanned, extraostial sites for ablation. CT‐fluoroscopy guidance decreased procedure duration and fluoro times (P < 0.05). At a mean follow‐up of 9 ± 2 months, 21 patients (84%) in the CT‐fluoro guidance group and 16 patients (64%) in the control group have had no recurrence of AF. Conclusion: CT‐fluoroscopic‐guided left atrial ablation is feasible and allows appropriate catheter manipulation in the left atrium.
- 30 January 2007
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 18 (4) , 409-414
Computed Tomography‐Fluoroscopy Image Integration‐Guided Catheter Ablation of Atrial Fibrillation
Introduction: This study examines the feasibility of atrial fibrillation (AF) ablation using registered three‐dimensional computed tomography (CT) images of the left atrium with fluoroscopy. Methods and Results: A total of 50 consecutive patients with symptomatic AF refractory to medical therapy (32 paroxysmal, 18 persistent, age 55 ± 10 years) were randomized to undergo a catheter‐based AF ablation procedure with or without the CT‐fluoroscopy guidance system. All patients underwent preprocedural contrast‐enhanced CT imaging and segmentation of the left atrium. For the CT‐fluoroscopy group, circumferential lesions encompassing the pulmonary vein (PV) antrum and linear lesions along the roof of the left atrium between the superior PVs and the mitral isthmus were created on the CT image, which was registered with real‐time fluoroscopy. The registered images were then used to navigate the ablation catheters to the sites of planned ablation. After the ablation sites were completed, any remaining PV potentials were isolated with electrophysiological guidance. In the control patients, the same technique was performed without using the CT‐fluoro guidance system. CT scans were accurately registered to fluoroscopic images with minimal manual correction. Operators could navigate catheters on the registered images to preplanned, extraostial sites for ablation. CT‐fluoroscopy guidance decreased procedure duration and fluoro times (P < 0.05). At a mean follow‐up of 9 ± 2 months, 21 patients (84%) in the CT‐fluoro guidance group and 16 patients (64%) in the control group have had no recurrence of AF. Conclusion: CT‐fluoroscopic‐guided left atrial ablation is feasible and allows appropriate catheter manipulation in the left atrium.